Omegaven Protocol:Intermediate Size Patient Population

NCT03561194 · clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

DHR Health Institute for Research and Development